A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2004
10/28/2004	WO2004091603A1 Use of an ester of dha for the treatment of cardiovascular diseases
10/28/2004	WO2004091602A1 Use of l-carnitine for the treatment of cardiovascular diseases
10/28/2004	WO2004091599A1 Method for the treatment of diseases linked to an accumulation of triglycerides and cholesterol
10/28/2004	WO2004091598A1 Use of beta-aminoisobutyric acid for the treatment of diseases linked to the accumulation of triglycerides and cholesterol
10/28/2004	WO2004091592A2 Methods and compositions to treat myocardial conditions
10/28/2004	WO2004091583A1 Chrono delivery formulations and method of treating atrial fibrillation
10/28/2004	WO2004091476A2 Method of screening remedy for heart disease and medicinal composition for treating heart disease
10/28/2004	WO2004083375A3 Methods of promoting the differentiation of stem cells
10/28/2004	WO2004078166A3 Use of omega-3-fatty acids in the treatment of diabetic patients
10/28/2004	WO2004072643A3 Diagnostics and therapeutics for diseases associated with glucagon-like peptide 2 receptor (glp2r)
10/28/2004	WO2004069806A3 Substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds
10/28/2004	WO2004047925A3 Therapeutic oxidation catalysts
10/28/2004	WO2004024094A3 Methods and compositons for the use of d-malic acid to decrease serum triglyceride, cholesterol, and lipoprotein levels
10/28/2004	WO2003105908A3 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
10/28/2004	WO2003095613A3 Nucleic acids, polypeptides, and methods for modulating apoptosis
10/28/2004	WO2003077840A3 Method of modulating inflammatory response
10/28/2004	WO2003030833A3 Angiopoietin-2 specific binding agents
10/28/2004	WO2003022882A3 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle
10/28/2004	WO2003018515A3 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
10/28/2004	WO2001081540A3 Growth factor which acts through erb b-4 rtk
10/28/2004	US20040215292 Photodynamic treatment of targeted cells
10/28/2004	US20040215251 Genetic modification of targeted regions of the cardiac conduction system
10/28/2004	US20040215023 Crystal and process for producing the same
10/28/2004	US20040215019 Substituted isoindoles and the e use thereof
10/28/2004	US20040215018 use as selective estrogen receptor modulators, and use in inhibiting bone loss, cardiovascular disease, and breast and uterine carcinoma
10/28/2004	US20040215014 Auroyl cyclic amines for controlling behavior or appetite
10/28/2004	US20040214996 Multimeric peptides/immunoglobulins for use in the treatment of bone disorders
10/28/2004	US20040214902 Small molecule antagonists of BCL-2 family proteins
10/28/2004	US20040214901 derivatives which inhibit pancreatic lipase and therefore can be used in combating or preventing obesity and hyperlipaemias
10/28/2004	US20040214892 Use of a lactate salt for the treatment and prophylaxis of atherosclerosis
10/28/2004	US20040214890 1,3-diamino-2-hydroxypropane derivatives are useful as inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal
10/28/2004	US20040214888 Carboxylic acid derivative and medicine comprising salt or ester of the same
10/28/2004	US20040214886 for the treatment and/or prophylaxis of diseases, in particular, states of pain and neurodegenerative disorders
10/28/2004	US20040214864 Novel compounds
10/28/2004	US20040214832 Piperazine derivative renin inhibitors
10/28/2004	US20040214830 2,7-Substituted octahydro-1H-pyrido[1,2-a]pyrazine derivatives as ligands for serotonin receptors
10/28/2004	US20040214826 Method of treating sexual disturbances
10/28/2004	US20040214825 Method of treating sexual disturbances
10/28/2004	US20040214824 treating sexual disorders using (5R)-5-(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinoline-2(1H)-thione
10/28/2004	US20040214823 Administering a fused aminoquinoline derivative such as (5R)-5-(methylamino)-5,6-dihydro-4H-imidazo(4,5,1-ij) quinoline-2(1H)-thione
10/28/2004	US20040214822 Substituted 4-aminocyclohexanol compounds
10/28/2004	US20040214820 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them
10/28/2004	US20040214815 Therapeutic compounds
10/28/2004	US20040214814 Pyrazole compounds useful as protein kinase inhibitors
10/28/2004	US20040214802 Dipyridamole, acetylsalicylic acid, and angiotensin II antagonist pharmaceutical compositions
10/28/2004	US20040214784 covalent conjugates with mono-, di- , poly- or thiaalkanoic acids; ability to adjust the solubility of steroidal molecules, lipophilicity and bioavailability by altering the structure and length of the acid chain; avoids or reduces the local irritation caused by the parent drug
10/28/2004	US20040214760 Inhibition pf protein-phosphatases for the treatment of heart failure
10/28/2004	US20040214759 Compositions and methods of use for a fibroblast growth factor
10/28/2004	US20040214756 administering mixtures of antithrombin and interleukins, tumor necrosis factors or enzyme inhibitors, for prophylaxis of infections
10/28/2004	US20040214286 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy
10/28/2004	US20040214275 Von willebrand factor (vmf)-cleaving enzyme
10/28/2004	US20040214264 Comprises nucleotide sequences coding dimethylarginine dimethylaminohydrolase-1 protein (DDAH1) for use in identifying modulators for treatment of diabetes and cardiovascular disorders
10/28/2004	US20040214234 Method
10/28/2004	US20040214182 Genetic modification of targeted regions of the cardiac conduction system
10/28/2004	US20040213797 Conjugates for the modulation of immune responses
10/28/2004	US20040213793 nucleic acid molecule encoding a transmembrane TEM1; Inhibiting neoangiogenesis by administering a molecule with an antibody variable region which specifically binds to an extracellular domain of a Tumor Endothelial Markers (TEMs) protein; polycystic kidney disease; psoriasis
10/28/2004	US20040213790 VEGF-related protein
10/28/2004	US20040213775 use of enzymes of the allene oxide synthase family for reducing myocardial ischemia reperfusion injury associated with myocardial infarction, thrombolysis, angioplasty and coronary bypass surgery
10/28/2004	US20040213762 A viral vector containing a nucleic acid sequence encoding V3 polypeptide or a biologically active fragment of the V3
10/28/2004	US20040213756 Methods and compositions to treat myocardial conditions
10/28/2004	US20040213442 Novel fatty acids analogous
10/28/2004	CA2559670A1 Stable amlodipine maleate formulations
10/28/2004	CA2526899A1 Method for the treatment of diseases linked to an accumulation of triglycerides and cholesterol
10/28/2004	CA2522266A1 Phenylazole compound, production process therefor and antioxidant
10/28/2004	CA2522143A1 A pharmaceutical composition containing an active agent having the effect of digitalis and a cgmp phosphodiesterase inhibitor
10/28/2004	CA2522118A1 Compounds that modulate ppar activity and methods of preparation
10/28/2004	CA2522076A1 Method for identifying modulators of g protein coupled receptor signaling
10/28/2004	CA2521836A1 Phosphates of secondary alcohols
10/28/2004	CA2521361A1 Chrono delivery formulations and method of treating atrial fibrillation
10/28/2004	CA2521175A1 Para-sulfonyl substituted phenyl compounds as modulators of ppars
10/28/2004	CA2520518A1 Method for treatment of angiogenic disorders
10/28/2004	CA2508636A1 Use of l-carnitine for the treatment of cardiovascular diseases
10/27/2004	EP1471066A1 Triaza- and tetraaza-anthracenedione derivates, their preparation and their use as pharmaceuticals
10/27/2004	EP1471064A1 Coumarin derivatives, process for their production and use thereof
10/27/2004	EP1471055A1 6-phenylpyridyl-2-amine derivatives
10/27/2004	EP1471054A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
10/27/2004	EP1471049A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
10/27/2004	EP1470826A1 Decoy-containing pharmaceutical compositions and method of using the same
10/27/2004	EP1470420A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
10/27/2004	EP1470246A2 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene
10/27/2004	EP1470240A2 Methods and compositions for treating cardiovascular disease using 1682, 6169, 6193, 7771, 14395, 29002, 33216, 43726, 69292, 21656, 32427, 2402, 7747,1720, 9151, 60491, 1371, 7077, 33207, 1419, 18036, 16105, 38650, 14245, 58848, 1870, 25856, 32394, 3484, 345, 9252, 9135, 10532, 18610, 8165,2
10/27/2004	EP1470231A2 Methods of obtaining isoform specific expression in mammalian cells
10/27/2004	EP1470150A2 Corticosteroids nitrate derivatives
10/27/2004	EP1470148A2 Double-stranded oligonucleotides
10/27/2004	EP1470144A2 Oligonucleotides comprising alternating segments and uses thereof
10/27/2004	EP1470143A1 Compounds that inhibit factor xa activity
10/27/2004	EP1470138A1 Mmp inhibitors
10/27/2004	EP1470137A1 Edg receptor agonists
10/27/2004	EP1470126A1 N-substituted spiropiperidine compounds as ligands for orl-1 receptor
10/27/2004	EP1470124A1 2-(PYRIDIN-2-YLAMINO)-PYRIDO 2,3-d]PYRIMIDIN-7-ONES
10/27/2004	EP1470122A1 Rho-kinase inhibitors
10/27/2004	EP1470121A1 Pyrimidine derivatives as rho-kinase inhibitors
10/27/2004	EP1470120A1 N-oxyde of n-phenyl-2-pyrimidine-amine derivatives
10/27/2004	EP1470112A1 Substituted pyridazinones as inhibitors of p38
10/27/2004	EP1470108A1 1,4-dihydropyridine and pyridine compounds as calcium channel blockers
10/27/2004	EP1470104A2 Novel compounds that inhibit factor xa activity
10/27/2004	EP1469898A1 A method and system for treating an atrial arrhythmia
10/27/2004	EP1469887A2 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids
10/27/2004	EP1469884A1 Aldosterone antagonist and non-steroidal anti-inflammatory agent combination therapy to prevent or treat cardiovascular disorders
10/27/2004	EP1469878A2 Fgfr agonists

1 ... 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 ... 1595